Literature DB >> 34281577

Corydalis saxicola Bunting total alkaloids attenuate paclitaxel-induced peripheral neuropathy through PKCε/p38 MAPK/TRPV1 signaling pathway.

Chu Xue1, Si-Xue Liu1, Jie Hu1, Jin Huang2, Hong-Min Liu1, Zhi-Xia Qiu1, Fang Huang3.   

Abstract

BACKGROUND: Corydalis saxicola Bunting, affiliated with the Papaveraceae Juss., has been proven to work well in anti-inflammation, hemostasis, and analgesia. This study was designed to observe the effect and potential mechanism of Corydalis saxicola Bunting total alkaloids (CSBTA) on paclitaxel-induced peripheral neuropathy (PIPN).
MATERIALS AND METHODS: Rats were injected 2 mg/kg paclitaxel 4 times and administrated with 30 or 120 mg/kg CSBTA. Mechanical and thermal allodynia and hyperalgesia were tested. After 40 days, serum was collected to detect PGE2, TNF-α, and IL-1β by ELISA. The L4-L6 segment spinal cord, DRG, and plantar skin were harvested, and Western-blot or RT-qPCR analyzed protein and gene levels of pro-inflammatory cytokines, p38 MAPK, PKCε, and TRPV1. The PIPN cell model was established with paclitaxel (300 nM, 5 d) in primary DRG neurons. We examined the effect of CSBTA (25 μg/ml or 50 μg/ml) by measuring the mRNA levels in PGE2, TNF-α and CGRP, and the protein expression on the PKCε/p38 MAPK/TRPV1 signaling pathway in the PIPN cell model.
RESULTS: The results showed that CSBTA effectively ameliorated allodynia and hyperalgesia, and regulated cytokines' contents (PGE2, TNF-α, and IL-1β) and neuropeptides (CGRP and SP) in different tissues in vivo. In addition, CSBTA significantly decreased cytokine gene levels of DRG neurons (PGE2, TNF-α, and CGRP) and the protein expressions of PKCε/p38 MAPK/TRPV1 signaling pathway in vivo and in vitro.
CONCLUSION: Therefore, CSBTA has a perspective therapeutic effect on the treatment of paclitaxel-induced peripheral neuropathy.
© 2021. The Author(s).

Entities:  

Keywords:  Corydalis saxicola Bunting total alkaloids; DRG neurons; Paclitaxel; Paclitaxel-induced peripheral neuropathy

Year:  2021        PMID: 34281577     DOI: 10.1186/s13020-021-00468-5

Source DB:  PubMed          Journal:  Chin Med        ISSN: 1749-8546            Impact factor:   5.455


  55 in total

Review 1.  Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.

Authors:  Marco Sisignano; Ralf Baron; Klaus Scholich; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2014-11-04       Impact factor: 42.937

Review 2.  Targeting TRPV1 for pain relief: limits, losers and laurels.

Authors:  Arpad Szallasi; Mohamed Sheta
Journal:  Expert Opin Investig Drugs       Date:  2012-07-11       Impact factor: 6.206

Review 3.  TRP channels and pain.

Authors:  David Julius
Journal:  Annu Rev Cell Dev Biol       Date:  2013       Impact factor: 13.827

4.  Cinobufacini protects against paclitaxel-induced peripheral neuropathic pain and suppresses TRPV1 up-regulation and spinal astrocyte activation in rats.

Authors:  Xiyuan Ba; Jiali Wang; Shiyang Zhou; Xinxin Luo; Yun Peng; Shimin Yang; Yue Hao; Guangyi Jin
Journal:  Biomed Pharmacother       Date:  2018-09-12       Impact factor: 6.529

5.  Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain.

Authors:  Y Chen; C Yang; Z J Wang
Journal:  Neuroscience       Date:  2011-07-14       Impact factor: 3.590

6.  The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4.

Authors:  Yan Li; Pavel Adamek; Haijun Zhang; Claudio Esteves Tatsui; Laurence D Rhines; Petra Mrozkova; Qin Li; Alyssa K Kosturakis; Ryan M Cassidy; Daniel S Harrison; Juan P Cata; Kenneth Sapire; Hongmei Zhang; Ross M Kennamer-Chapman; Abdul Basit Jawad; Andre Ghetti; Jiusheng Yan; Jiri Palecek; Patrick M Dougherty
Journal:  J Neurosci       Date:  2015-09-30       Impact factor: 6.167

7.  Presynaptic N-Methyl-d-aspartate (NMDA) Receptor Activity Is Increased Through Protein Kinase C in Paclitaxel-induced Neuropathic Pain.

Authors:  Jing-Dun Xie; Shao-Rui Chen; Hong Chen; Wei-An Zeng; Hui-Lin Pan
Journal:  J Biol Chem       Date:  2016-07-25       Impact factor: 5.157

8.  Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion.

Authors:  Tomomi Hara; Terumasa Chiba; Kenji Abe; Akiko Makabe; Souichi Ikeno; Kazuyoshi Kawakami; Iku Utsunomiya; Toshihiro Hama; Kyoji Taguchi
Journal:  Pain       Date:  2013-03-04       Impact factor: 6.961

9.  Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.

Authors:  Haijun Zhang; Jessica A Boyette-Davis; Alyssa K Kosturakis; Yan Li; Seo-Yeon Yoon; Edgar T Walters; Patrick M Dougherty
Journal:  J Pain       Date:  2013-05-31       Impact factor: 5.820

10.  Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons.

Authors:  Natalie A Duggett; Lisa A Griffiths; Sarah J L Flatters
Journal:  Pain       Date:  2017-08       Impact factor: 7.926

View more
  3 in total

Review 1.  The Traditional Uses, Phytochemistry, Pharmacokinetics, Pharmacology, Toxicity, and Applications of Corydalis saxicola Bunting: A Review.

Authors:  Yanru Guo; Linjun Zhao; Botao Chang; Jia Yu; Jiangping Bao; Qi Yao; Jun Luo
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

2.  Cucurbitacin B inhibits TGF-β1-induced epithelial-mesenchymal transition (EMT) in NSCLC through regulating ROS and PI3K/Akt/mTOR pathways.

Authors:  Renyikun Yuan; Qiumei Fan; Xiaowei Liang; Shan Han; Jia He; Qin-Qin Wang; Hongwei Gao; Yulin Feng; Shilin Yang
Journal:  Chin Med       Date:  2022-02-19       Impact factor: 5.455

3.  Effect of electroacupuncture on cyclic adenosine monophosphate-protein kinase A-vanillic acid receptor subtype 1 of the transient receptor potential/PLK-protein kinase C-vanillic acid receptor subtype 1 of the transient receptor potential pathway based on RNA-seq analysis in prostate tissue in rats with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Xiao-Ling Wu; Kai Cheng; Chang Xu; Ye-Mao Chai; Tai-Heng Yap; Zhi-Wen Yang; Qian-Hui Sun; Yan Tan; Jia-Ni Zhang; Wei Chen; Xing-Hua Qiu; Xing-Yue Yang; Na Li
Journal:  Front Neurosci       Date:  2022-08-24       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.